Effect of Intraocular Tamponade on Visual Perception

NCT ID: NCT05543018

Last Updated: 2022-09-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-09-12

Study Completion Date

2023-10-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Intraocular tamponade used in vitrectomy operations may affects retinal function in various mechanisms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Various intraocular tamponade are being used in vitrectomy operations as gases, fluids and silicon oil. The effects of these intraocular tamponade may affects the final visual outcome of the surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinal Detachment Optic Neuropathy Glaucoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Silicon oil group

Patients diagnosed with retinal detachment and undergone vitrectomy operation with silicon oil tamponade.

Group Type ACTIVE_COMPARATOR

Electroretinogram

Intervention Type DIAGNOSTIC_TEST

Retinal function assessment using electroretinogram

Vitrectomy operation

Intervention Type PROCEDURE

Vitrectomy operation to treat retinal detachment

Air tamponade

Patients diagnosed with retinal detachment and undergone vitrectomy operation with air tamponade.

Group Type ACTIVE_COMPARATOR

Electroretinogram

Intervention Type DIAGNOSTIC_TEST

Retinal function assessment using electroretinogram

Vitrectomy operation

Intervention Type PROCEDURE

Vitrectomy operation to treat retinal detachment

Non-expansile gas

Patients diagnosed with retinal detachment and undergone vitrectomy operation with non-expansile gas tamponade (sulfur hexafluoride).

Group Type ACTIVE_COMPARATOR

Electroretinogram

Intervention Type DIAGNOSTIC_TEST

Retinal function assessment using electroretinogram

Vitrectomy operation

Intervention Type PROCEDURE

Vitrectomy operation to treat retinal detachment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electroretinogram

Retinal function assessment using electroretinogram

Intervention Type DIAGNOSTIC_TEST

Vitrectomy operation

Vitrectomy operation to treat retinal detachment

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* primary retinal detachment patients.
* patients eligible for 23 gauge pars-plana vitrectomy operation.

Exclusion Criteria

* patients with axial length more than 30 millimeter that may have severe chorioretinal degenerations that may affects retinal function.
* patients with macular diseases that may affects final visual outcome as macular holes and choroidal neovascular membranes.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Benha University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed Abdelshafy

Lecturer of Ophthalmology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ahmed A Tabl, MD

Role: PRINCIPAL_INVESTIGATOR

Benha University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ahmed Abdelshafy Tabl

Banhā, Benha, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ahmed A Tabl, MD

Role: CONTACT

01222328766

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ahmed A Tabl

Role: primary

01222328766

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC-10-22

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.